Article
Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.
Nature genetics - 1 Dec 2005
Bell Daphne W, Gore Ira, Okimoto Ross A, Godin-Heymann Nadia, Sordella Raffaella, Mulloy Roseann, Sharma Sreenath V, Brannigan Brian W, Mohapatra Gayatry, Settleman Jeff, Haber Daniel A
Abstract excerpt
Somatic activating mutations in EGFR identify a subset of non-small cell lung cancer that respond to tyrosine kinase inhibitors. Acquisition of drug resistance is linked to a specific secondary somatic mutation, EGFR T790M. Here we describe a family with multiple cases of non-small cell lung cancer associated with germline transmission of this mutation. Four of six tumors analyzed showed a secondary somatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
